did the fda ban tirzepatide 🚨 Moves to Shut Down Mass-Market Compounded GLP-1s FDA is taking action to restrict widely marketed, non–FDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand A Major GLP-1 Drug Shortage
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

























